Group One Trading’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-20,381
| Closed | -$968K | – | 8027 |
|
|
2025
Q3 | $968K | Sell |
20,381
-5,336
| -21% | -$258K | ﹤0.01% | 3069 |
|
|
2025
Q2 | $1.37M | Sell |
25,717
-4,063
| -14% | -$185K | ﹤0.01% | 2476 |
|
|
2025
Q1 | $1.21M | Buy |
+29,780
| New | +$1.26M | ﹤0.01% | 2285 |
|
|
2024
Q2 | – | Sell |
-2,416
| Closed | -$51.7K | – | 6643 |
|
|
2024
Q1 | $61K | Sell |
2,416
-35,455
| -94% | -$852K | ﹤0.01% | 4545 |
|
|
2023
Q4 | $884K | Buy |
37,871
+12,853
| +51% | +$253K | ﹤0.01% | 2563 |
|
|
2023
Q3 | $1.27M | Sell |
25,018
-55,546
| -69% | -$2.59M | ﹤0.01% | 2039 |
|
|
2023
Q2 | $3.76M | Buy |
80,564
+80,417
| +54,705% | +$3.69M | 0.01% | 1185 |
|
|
2023
Q1 | $5.62K | Sell |
147
-124,481
| -100% | -$5.55M | ﹤0.01% | 6230 |
|
|
2022
Q4 | $6.83M | Buy |
124,628
+124,573
| +226,496% | +$5.34M | 0.02% | 960 |
|
|
2022
Q3 | $2K | Sell |
55
-745
| -93% | -$11.4K | ﹤0.01% | 7103 |
|
|
2022
Q2 | $8K | Sell |
800
-8,600
| -91% | -$89.7K | ﹤0.01% | 6857 |
|
|
2022
Q1 | $133K | Buy |
+9,400
| New | +$165K | ﹤0.01% | 5215 |
|
|
2021
Q2 | – | Sell |
-43,885
| Closed | -$1.23M | – | 8087 |
|
|
2021
Q1 | $1.27M | Buy |
43,885
+43,819
| +66,392% | +$1.33M | ﹤0.01% | 2951 |
|
|
2020
Q4 | $2K | Hold |
66
| – | – | ﹤0.01% | 6220 |
|
|
2020
Q3 | $2K | Sell |
66
-2,138
| -97% | -$74.7K | ﹤0.01% | 5798 |
|
|
2020
Q2 | $55K | Sell |
2,204
-1,237
| -36% | -$28.3K | ﹤0.01% | 4284 |
|
|
2020
Q1 | $73K | Buy |
+3,441
| New | +$73.8K | ﹤0.01% | 3501 |
|
Other funds holding AKRO
Group One Trading's AKRO Position: Q4 2025 in Review
Group One Trading sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 20,381 shares — an estimated $968K sold.
Group One Trading first reported a position in AKRO in Q1 2020 and held it in 17 quarters. The position peaked at $6.83M in Q4 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Group One Trading reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 20,381 Akero Therapeutics shares in Q4 2025, an estimated $968K.
- Group One Trading first reported a position in Akero Therapeutics in Q1 2020 and held it in 17 quarters.
- Group One Trading's Akero Therapeutics position peaked at $6.83M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.